Comparer des méthodes

	FACT-Anémie : Évaluation fonctionnelle de la thérapie du cancer	FACT-Lung : Évaluation fonctionnelle des thérapies anticancéreuses
Domaine	Oncologie	Oncologie
Famille	Process / pipeline	Process / pipeline
Année d'origine	1997	1995
Auteur d'origine	Yellen, S. B., Cella, D. F., et al. (built on Cella, D. F. FACT-G framework)	David F. Cella, Ph.D.
Type	Self-report questionnaire	Self-report questionnaire
Source fondatrice	Yellen, S. B., Cella, D. F., Webster, K., Blendowski, C., & Kaplan, E. (1997). Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage, 13(2), 63–74.	Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E., & Bonomi, P. (1995). Validation of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument for patients with lung cancer. J Clin Oncol, 13(1), 142–153.
Alias	FACT-An	FACT-L
Apparentées	5	5
Résumé	The FACT-Anemia (FACT-An) is a quality-of-life measure combining the 27-item FACT-G core with a disease-specific subscale focusing on fatigue and anemia-related symptoms common in cancer patients receiving chemotherapy or dealing with cancer-induced anemia. Developed by Yellen et al. in 1997, it quantifies the impact of chemotherapy-induced anemia on functional and emotional well-being, supporting clinical trials and anemia treatment research.	The FACT-Lung (FACT-L) is a lung-cancer-specific quality-of-life measure that combines a 27-item general cancer assessment with a 7-item lung cancer subscale. Developed by Cella et al. in 1995, it quantifies physical, emotional, social, and functional well-being specifically relevant to lung cancer patients. It is widely used in clinical trials and practice to assess treatment impact and symptom burden.